Usefulness of Outpatient Pharmacist Interventions for Lenvatinib-treated Patients
-
Published:2021-11-10
Issue:11
Volume:47
Page:623-630
-
ISSN:1346-342X
-
Container-title:Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
-
language:en
-
Short-container-title:Jpn. J. Pharm. Health Care Sci.
Author:
Katsuragawa Miki1, Oshita Kohime1, Yamashita Yuki1, Ishizuka Niho1, Matsuki Yuri1, Okubo Rinka1, Shibanami Akio1, Hiura Kazuya2
Affiliation:
1. Hospital Pharmacy, Sapporo Kosei General Hospital 2. Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University of Science
Publisher
Japanese Society of Pharmaceutical Health Care and Sciences
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference10 articles.
1. 1）土谷順彦, 羽渕友則, 固形腫瘍における分子標的薬の現状と課題, Drug Delivery System, 2010, 25, 134-142. 2. 2）小野寛之, 龍田涼佑, 中原良介, 田中遼大, 伊東弘樹, 肝細胞がん患者を対象とした薬剤師によるlenvatinib外来への介入とその有用性の検討, 医療薬学, 2020, 46, 303-313. 3. 5）栗山朋子, 山本和宏, 池田剛久, 橋本正良, 西岡達也, 比米 学, 槇本博雄, 矢野育子, 平井みどり, 「薬剤師外来」における薬学的処方介入とその評価, 医療薬学, 2017, 44, 169-175. 4. 7）加藤良隆, 江島智彦, 三木有咲, 溝口貴大, 村上 怜, 神田英一郎, 野口裕介, 澤田真嗣, 村木優一, 田渕祐輔, 四方敬介, 友金幹視, 薬剤師外来とテレフォンフォローアップを利用し病院薬剤師と保険薬局薬剤師が連携・介入した一例 －外来がん化学療法施行患者への介入を通して－, 医療薬学, 2020, 46, 22-30. 5. 9）Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Piscaglia F, Baron A, Park JW, Han G, Jassem J, Blanc JF, Vogel A, Komov D, Evans TRJ, Lopez C, Dutcus C, Guo M, Saito K, Kraljevic S, Tamai T, Ren M, Cheng AL, Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial, Lancet, 2018, 391, 1163-1173.
|
|